Dr. Robert Hoffman, MD | New York, NY - US News Health
health.usnews.com
Atsushi Suetsugu, Kimi Honma, Shigetoyo Saji, Hisataka Moriwaki, Takahiro Ochiya, Robert M. Hoffman. Fluorescence-Guided Surgery and Fluorescence ... › Doctors
SiRNA & miRNA gene silencing: from bench to bedside ...
www.lavoisier.eu
... Kimi Honma, and Takahiro Ochiya Imaging of siRNA Delivery and Silencing Anna Moore and Zdravka Medarova Recent Advances in Magnetofection and Its ... › sioud › description_
HONMA, Fumitaka: مفت ڈاؤنلوڈ. ای بک لائبریری۔ Z-Library پر آن ...
ur.booksc.eu
Application of Atelocollagen-Mediated siRNA Delivery for RNAi Therapies · Kimi Honma, Fumitaka Takeshita, Takahiro Ochiya. › author
Miyata, Kimie: मुफ़्त में डाउनलोड. ई-बुक पुस्तकालय. Z-Library में ...
hi.art1lib.org
Type I collagen gene suppresses tumor growth and invasion of malignant human glioma cells · Kimi Honma, Teruo Miyata, Takahiro Ochiya. पत्रिका:. › author
siRNA and miRNA Gene Silencing - Weltbild
www.weltbild.de
... Kimi Honma, and Takahiro Ochiya Imaging of siRNA Delivery and Silencing Anna Moore and Zdravka Medarova Recent Advances in Magnetofection and Its ... › buch › sirn...
siRNA and miRNA Gene Silencing - Booktopia
www.booktopia.com.au
... Kimi Honma, and Takahiro Ochiya Imaging of siRNA Delivery and Silencing Anna Moore and Zdravka Medarova Recent Advances in Magnetofection and Its ... › book
siRNA and miRNA Gene Silencing By Mouldy Sioud | New Book
www.wob.com
26 May — ... Naomi Hokaiwado, Kimi Honma, and Takahiro Ochiya Imaging of siRNA Delivery and Silencing Anna Moore and Zdravka Medarova Recent Advances ... › ... › Biology & life sciences
学术圈 – Kimi Honma
www.soscholar.com
Gene expression profiling of cerebellar development with high-throughput functional analysis · Sakae Saito , Kimi Honma , Hiroko Kita-Matsuo , Takahiro Ochiya ...
Live-cell luciferase assay of drug resistant Research Square
www.researchsquare.com
by K Honma · · Cited by 2 — Kimi Honma. Section for Studies on Metastasis, Japanese National Cancer Center Research Institute. Takahiro Ochiya. › nprot-481
Atelocollagen-Based Gene Transfer in Cells Allows High ...
www.sciencedirect.com
by K Honma · · Cited by 110 — Kimi Honma,* Takahiro Ochiya,† Shunji Nagahara,‡ Akihiko Sano,‡ Hanako Yamamoto,†. Kotaro Hirai,† Yu Aso,* and Masaaki Terada†,1. › science › article › pii › pdf
Advanced Drug Delivery Reviews | Exosomes; a key to delivering...
www.sciencedirect.com
Exosomes; a key to delivering genetic materials. Edited by Takahiro Ochiya, Jan Lötvall. Volume 65, Issue 3, ... Kimi Honma, Shigetoyo Saji, Hisataka Moriwaki, ...
Screening of potential molecular targets for colorectal cancer therapy
www.ncbi.nlm.nih.gov
Screening of potential molecular targets for colorectal cancer therapy. Kimi Honma, Ichiro Takemasa, [...], and Takahiro Ochiya. Additional article information ...
Atelocollagen-Based Gene Transfer in Cells Allows High-Throughput...
www.sciencedirect.com
Kimi Honma,* Takahiro Ochiya,† Shunji Nagahara,‡ Akihiko Sano,‡ Hanako Yamamoto,†. Kotaro Hirai,† Yu Aso,* and Masaaki Terada†,1. *Koken Bioscience ...
Cancer Cell International - BioMedSearch
www.biomedsearch.com
Email: Kimi Honma - .jp; Teruo Miyata - tmiyata@ kokenmpc.co.jp; Takahiro Ochiya* - .jp.
RPN2 is essential for the maintenance of the CSC …
www.nature.com
Figure 1: RPN2 is essential for the maintenance of the CSC fraction Kimi Honma & Takahiro Ochiya; Division of Chemotherapy and Clinical Research, ...
All web results to the name "Kimi Honma"
US A1 - Use of rpn2 gene expression inhibitor
www.google.com.pg
Application number: US ,888; Other versions: US B2 (en; Inventor: Takahiro Ochiya: Kikuya Kato: Kimi Honma: Yasuji Ueda; Current Assignee (The ... › patents
Exosomes from adriamycin-resistant breast cancer cells ...
biokde.com
Atsushi Suetsugu, Kimi Honma, +3 authors, Shigetoyo Saji, Hisataka Moriwaki, Takahiro Ochiya, Robert M Hoffman. less. Adv Drug Deliv Rev, Aug 28; ... › doc
Osaka University - Kurokawa Yukinori - 大阪大学 研究者総覧
rd.iai.osaka-u.ac.jp
... Yukinori Kurokawa,Kimi Honma,Ichiro Takemasa,Shoji Nakamori,Hiroko Kita-Matsuo,Masaaki Motoori,Hiroaki Nagano,Keizo Dono,Takahiro Ochiya,Morito Monden ... › ...
Potential of Atelocollagen-Mediated Systemic Antisense ...
www.liebertpub.com
Kimi HONMA, Fumitaka TAKESHITA, Takahiro OCHIYA Application of Atelocollagen- mediated siRNA Delivery for RNAi Therapies. YAKUGAKU ZASSHI 127:5, ... › doi › pdfplus
pLenti-C-Myc-DDK Lentiviral Gene Expression Vector - OriGene
www.origene.cn
... Kimi Honma, Masaya Ono, Kikuya Kato & Takahiro Ochiya, Scientific Reports 3, doi: srep ,PubMed ID [pLenti-C-Myc-DDK] ... › catalog › plenti-c-myc-ddk-le...
siRNA and miRNA gene silencing : from bench to bedside - ULB
cibleplus.ulb.ac.be
... and Systemic Delivery of siRNAs for Oligonucleotide Therapy / Fumitaka Takeshita, Naomi Hokaiwado, Kimi Honma, Agnieszka Banas and Takahiro Ochiya › discovery › fulldisplay
当前药物发现技术，卷1 - 4
m.botasespana.com
Kimi Honma, Teruo Miyata和Takahiro Ochiya. DOI: · 视图抽象 权限 订单再版 eprint顺序 · 视图抽象 · 质谱技术在药物发现中的应用:综述. › issue
EP A1 - Use of rpn2 gene expression inhibitor - Google
patents.google.com
Download PDF Find Prior Art Similar. Other languages: German: French; Inventor: Kimi Honma: Kikuya Kato: Takahiro Ochiya: Yasuji Ueda; Current Assignee.
WO A1 - 核酸導入用セルトランスフェクションアレイ - Google ...
patents.google.com
Other languages: English: French: Japanese; Inventor: Kimi Honma: Takahiro Ochiya; Original Assignee: Koken Co., Ltd. Dainippon Sumitomo Pharma Co., Ltd.
Current Drug Discovery Technologies, Volume 1 - Number 4
www.benthamscience.com
Kimi Honma, Teruo Miyata and Takahiro Ochiya. DOI: · View Abstract Permissions Order Reprints Order Eprints · View Abstract ...
DataCite Search
search.datacite.org
Kimi Honma, Teruo Miyata & Takahiro Ochiya. Figure published via Figshare. Copyright information:Taken from "Type I collagen gene suppresses tumor ...
DE D1 - Verfahren zur förderung des nukleinsäuretransfers...
patents.google.com
Inventors, Masaaki Terada, Takahiro Ochiya, Yu Aso, Kimi Honma, Akihiko Sano, Shunji Nagahara. Applicant, Dainippon Sumitomo Pharma Co, Koken Kk.
US A1 - Use of rpn2 gene expression inhibitor ...patents.google.com › patent
patents.google.com
... versions: US B2 (en; Inventor: Takahiro Ochiya: Kikuya Kato: Kimi Honma: Yasuji Ueda; Current Assignee (The listed assignees may be inaccurate.
Atelocollagen-mediated drug discovery technology | Read by QxMD
read.qxmd.com
Takahiro Ochiya, Kimi Honma, Fumitaka Takeshita, Shunji Nagahara. Expert Opinion on Drug Discovery 2007, 2 (2): RNA interference (RNAi) was first ...
Optical imaging of RNAi-mediated silencing of cancerwww.spiedigitallibrary.org › full
www.spiedigitallibrary.org
Takahiro Ochiya, Kimi Honma, Fumitaka Takeshita, and Shunji Nagahara "Optical imaging of RNAi-mediated silencing of cancer", Proc.
RPN2 gene confers docetaxel resistance in breast cancerscite.ai › reports
scite.ai
Kimi Honma, Kyoko Iwao-Koizumi, Fumitaka Takeshita, Yusuke Yamamoto, Teruhiko Yoshida, Kazuto Nishio, Shunji Nagahara, Kikuya Kato, Takahiro Ochiya.
The Role of Atelocollagen-Based Cell Transfection Array in Highwww.eurekaselect.com › article › role-atelocollagen-based-cell-transfecti...
www.eurekaselect.com
Author(s): Kimi Honma, Teruo Miyata, Takahiro Ochiya. Section for Studies on Metastasis, National Cancer Center, 1-1, Tsukiji 5-chome, Chuo-ku, ...
Type I collagen gene suppresses tumor growth and invasion of...
read.qxmd.com
Kimi Honma, Teruo Miyata, Takahiro Ochiya. Cancer Cell International 2007, 7: 12. BACKGROUND: Invasion is a hallmark of a malignant tumor, such as a ...
sorted by relevance / date